GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Marketable Securities

Curocell (XKRX:372320) Marketable Securities : ₩17,000.00 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Curocell's Marketable Securities for the quarter that ended in Jun. 2023 was ₩17,000.00 Mil.

Curocell's annual Marketable Securities increased from Dec. 2021 (₩19,800.00 Mil) to Dec. 2022 (₩32,500.00 Mil) but then declined from Dec. 2022 (₩32,500.00 Mil) to Dec. 2023 (₩32,000.00 Mil).


Curocell Marketable Securities Historical Data

The historical data trend for Curocell's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Marketable Securities Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
7,000.00 37,601.25 19,800.00 32,500.00 32,000.00

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Marketable Securities - 32,500.00 17,000.00 32,000.00

Curocell Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Curocell  (XKRX:372320) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Curocell Marketable Securities Related Terms

Thank you for viewing the detailed overview of Curocell's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines